Recent Posts
Archives
IRD's top Christmas picks - Part 1: Jane Lowe.

Our present to you
We have had an outstanding year at IR Department. We’ve worked with fantastic clients, we’ve had loads of new opportunities and have witnessed some great successes – from IPOs to rising share prices, to successful capital raises and media/comms outcomes. It’s been pretty good all-round.
Should small and microcap companies be using social media?

When used appropriately, social media can be an important communication channel for every business, and small caps are no exception.
We find that only a handful of our clients are still resistant to using social media; most conversations are centred around which platforms they should be on and how they could be better using them.
What is a quarterly report and why you, as an investor, should read it

What is a quarterly report? Why do some companies produce a quarterly report and not others? How should investors interpret a quarterly report?
IR Department’s Investor Relations Specialist Glen Zurcher sat down with Tom Piotrowski recently to discuss quarterly reporting – technically referred to as an Appendix 4C / Appendix 5B - as part of the CommSec Executive Series.
Key themes emerging in digital healthcare right now

Elementum Advisory Principal Philippa Lewis works predominantly with emerging Australian companies to build an investor-ready business.
In this interview with Health Invest TV, Phillipa talks to IR Department Managing Director Jane Lowe about effective business models, the traps she frequently sees young companies falling into, and the exciting start-ups she's working with right now.
Watch: 3 quick tips to give a winning media interview every time

Innovating sleep apnoea care

Sleep apnoea is a potentially serious condition but only one in five patients are in care.
Oventus (ASX:OVN) is innovating sleep apnoea care with its patented airway design that creates a 'second nose'. Using CAD software to create a 3D drawing of the patient’s mouth and bite, Oventus uses 3D printing technology to manufacture these custom-made medical-grade mouthguards from titanium.
Getting the most from your roadshow

Half yearly reporting season for ASX listed companies with a 30 June year end has just finished up. For IR Department, the start of March typically signals the time when our smaller ASX listed company clients would want to roadshow. Some companies, however, will be deliberating over how important roadshows are.
Why M&A is a major investment theme for 2018

Around 22,000 people attended the JP Morgan Healthcare Conference 2018 in San Francisco.
Australian broker Paul Kelly has attended the conference for the past five years. Speaking to Health Invest TV in an interview with IR Department's Managing Director, Jane Lowe, Paul gives you a first-hand account of what happens over the week.
New LinkedIn features you should care about

LinkedIn plays a pivotal role in our communication strategies because it’s the biggest B2B social marketing platform out there.
Whether or not you should be using LinkedIn is a subject for another day – right now we just want to tell you about two new features that small to mid capped companies should care about.
How small caps can communicate better with investors: Three tips from an award-winning financial planner

3 key things an analyst looks at when researching a small company

There is a reason ‘small cap’ specialists are engaged to invest in small cap stocks - there are some key areas of focus for small stock investing that are often taken for granted in large cap investing.
IR Department senior consultant John Burgess has almost 20 years’ experience as an analyst across a range of sectors and companies. John explores three key focus areas of analysis that differ between small and large cap stocks. If you're a small company, it pays to bear these in mind when undertaking investor relations.
How useful is independent research? Heard of MiFID II?

In this episode of Swings & Roundabouts, Marc Kennis of TMT Analytics and Stuart Roberts of NDF Research explore the wide-sweeping implications of MiFID II, particularly for company research.
IR Department and DEC PR support Skyfii (ASX: SKF)

AdAlta's Sam Cobb on the company's unique antibody platform

Novogen's Dr James Garner explores the company's transformation

Innovations, with David Langford

Today on Swings and Roundabouts, David Langford, Managing Director and Chief Investment Analyst with Long Lake Research speaks with Jane Lowe about contrarian investing and the need for Australian companies to innovate or get left behind.
IPOs with Patricia Doyle

Market Report - with Matt Felsman

Today on Swings and Roundabouts, Matt Felsman, Client Advisor with APP Securities speaks with Jane Lowe about reporting season.
Introducing Swings and Roundabouts

IR Department is pleased to announce a new regular digital radio show, Swings and Roundabouts.
Putting on your PM hat

If you're marketing your business to funds, knowing what portfolio managers want to see and hear from you is of great importance.